Brazil Veterinary Vaccines Market: Market Size & Forecast 2026

Brazil stands as one of the largest veterinary medicine markets in Latin America and ranks among the most significant globally, given its position as a top exporter of beef, poultry, and pork. The country's overall veterinary medicine market was valued at approximately $2.65 billion in 2024 and is forecast to grow to $4.15 billion by 2030 at a 7.9% CAGR, with vaccines representing a high-growth biologics segment within that broader landscape. The sector benefits from a deeply integrated supply chain that links vaccine manufacturers, distributors, and veterinary practitioners across all major regions of the country.

• •Market valued at approximately $1.11 billion in 2025, projected near $1.77 billion by 2030
• •9.7% CAGR reflects one of the faster growth rates among global veterinary vaccine markets
• •Part of a broader $2.65 billion veterinary medicine market in Brazil (2024 base)

Cattle disease outbreaks, including foot-and-mouth disease, bovine brucellosis, and anthrax, remain a persistent threat and have led authorities to maintain strict, mandatory vaccination schedules for bovines nationwide. The expanding livestock population, particularly in the Center-West cattle ranching regions, is directly correlated with higher vaccine consumption volumes. On the companion animal side, increasing urbanization, rising disposable incomes, and growing awareness of pet health are driving steady demand for canine and feline vaccines.

• •Disease outbreaks and mandatory government vaccination protocols are the single largest demand catalyst
• •Brazil's position as a top global beef exporter requires compliance with rigorous animal health and biosecurity standards
• •Companion animal segment is expanding rapidly, fueled by growing pet adoption and health awareness among urban households

The market is broadly divided by animal type into livestock vaccines, encompassing cattle, swine, and poultry, and companion animal vaccines for dogs and cats. Cattle vaccines dominate the livestock segment, representing the single largest revenue contributor, followed by swine and poultry vaccines tied to Brazil's industrial-scale production systems. Geographically, demand is strongest in the Center-West and Southeast regions, where the bulk of commercial cattle ranching, pork production, and pet-owning urban populations are concentrated.

• •Cattle vaccines lead the livestock segment; swine and poultry vaccines follow with significant volumes
• •Center-West region, including Mato Grosso, Goiás, and Mato Grosso do Sul, is the primary demand hub for livestock vaccines
• •Southeast urban centers (São Paulo, Rio de Janeiro) drive the companion animal vaccine market

What are the recent trends and outlook?

Live attenuated vaccines continue to represent a prominent product category within the market, favored for their efficacy and cost-effectiveness in large-scale herd immunization programs. Advances in vaccine technology, including recombinant and marker vaccines, are gradually gaining adoption as producers seek to meet more stringent import requirements from key export markets. With export-driven demand unlikely to subside and domestic consumption of animal protein and companion animal services on an upward trajectory, the market is well-positioned for sustained double-digit growth through the end of the decade.

• •Live attenuated vaccines remain a leading product type; recombinant and marker vaccines are gaining ground
• •Export market requirements are pushing producers toward higher-quality and next-generation vaccine solutions
• •Sustained growth expected through 2030, with trajectory supported by both livestock and companion animal demand